Drugs / hetastarch
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT00796419 | Jan 2009 → Nov 2015 | acute lung injury, acute respiratory distress syndrome | Emory University | Terminated | No outcome recorded |
| Phase 3 | NCT00307138 | Sep 2004 → Aug 2005 | — | Kaiser Permanente | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00469716 | Apr 2007 → May 2008 | respiratory failure | Haukeland University Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03350217 Comparator | Oct 2017 → Jan 2019 | bleeding disorder, vascular-type, hemorrhagic disease | Indiana University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hetastarch | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00796419 ↗ |
| Modality | Other / unclassified | “Hetastarch is an artificial colloid widely used intraoperatively in fluid-replacement regimens.” PMID 19698859 ↗ May 2009 |
| Route | Intravenous | “Intravenous administration” NCT00796419 ↗ |